Samuel Gershon
About
In The Last Decade
Samuel Gershon
371 papers receiving 10.5k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Psychiatry and Mental health 4.9k
- Cellular and Molecular Neuroscience 3.9k
- Molecular Biology 2.1k
- Pharmacology 2.1k
- Cognitive Neuroscience 1.6k
Countries citing papers authored by Samuel Gershon
This map shows the geographic impact of Samuel Gershon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Gershon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Gershon more than expected).
Fields of papers citing papers by Samuel Gershon
This network shows the impact of papers produced by Samuel Gershon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Gershon. The network helps show where Samuel Gershon may publish in the future.
Co-authorship network of co-authors of Samuel Gershon
This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Gershon. A scholar is included among the top collaborators of Samuel Gershon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Gershon. Samuel Gershon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 16 | |
| 4 | 6 | |
| 5 | 5 | |
| 6 | 7 | |
| 7 | 19 | |
| 8 | 48 | |
| 9 | History of antidepressants: successes and failures. | 8 |
| 10 | Effect of lithium on the membrane-bound magnesium-dependent ATPase of mouse neuroblastoma cells. | 1 |
| 11 | Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects. | 21 |
| 12 | Psychopharmacology of aging: current trends. | 1 |
| 13 | Psychopathology and brain dysfunction | 101 |
| 14 | A morphanthridine derivative in schizophrenic patients -- lack of extrapyramidal symptoms. | 2 |
| 15 | MJ 9022: correlation between neuroleptic potential and stereotypy. | 40 |
| 16 | 67 | |
| 17 | Cyprolidol and imipramine: a double-blind controlled study in endogenous depression. | 1 |
| 18 | 7 | |
| 19 | Effects of psychoactive drugs on yohimbine induced responses in conscious dogs. A proposed screening procedure for anti-anxiety agents. | 39 |
| 20 | 231 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.